Human Papillomavirus (HPV) infections are more prevalent and persistent in HIV-infected individuals — HPV prevalence rates of 76% in HIV-infected women compared to the 46% prevalence rate in HIV-uninfected women. Cervical prevalence rates are also higher in HIV-infected women — between 48-73% in case compared to 28% in HIV-uninfected women. Additionally, HPV infections and HPV-associated diseases appear to exert a disproportionately higher burden of disease in HIV-infected women as opposed to HIV-uninfected women.
Full Citation:
Kojic, E.M., Rana, A.I., and Cu-Uvin, A.. 2016. Human Papillomavirus vaccination in HIV-infected women: need for increased coverage. Expert Review of Vaccines. 15(1).
Title of Article: Human Papillomavirus vaccination in HIV-infected women: need for increased coverage
Author(s): Kojic, E.M., Rana, A.I., and Cu-Uvin, A.
Publication Year: 2016
Publication Name: Expert Review of Vaccines
Publication Volume: 15(1)
Publication Source URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4825670/
DOI (Digital Object Identifier): 10.1586/14760584.2016.1110025